Document Type : Case Report


1 Cardiovascular Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran

2 Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran


BACKGROUND: Carbon monoxide (CO) poisoning is the leading cause of poisoning-related deaths in the
United States. In addition, myocardial infarction (MI) due to CO poisoning in a young, healthy adult is rare.
On the other hand, smokeless tobacco, processed in various forms, is a controversial coronary heart disease
(CHD) risk factor.
CASE REPORT: In this study, we describe a 29-year-old man who presented with acute chest pain following
a night of smoking tobacco and using smokeless tobacco in the presence of carbon monoxide poisoning.
ST-segment elevation was observed on an electrocardiogram, and echocardiography revealed akinesia. In
addition, cardiac markers were elevated. In this particular instance, thrombolytic therapy demonstrated
successful outcomes.
CONCLUSIONS: We believe the case and discussion could shed light on the emergency department
management of such individuals. We advise clinicians to consider the possibility of coronary heart disease
in carbon monoxide poisoning patients and to obtain a baseline electrocardiogram and cardiac markers.


The Google Schoolar and PubMed links for Farbod Hatami.



1- Centers for Disease Control, Prevention (CDC). Carbon monoxide exposures– United States, 2000–2009. MMWR Morb Mortal Wkly Rep 2011;60:1014–7.
2- Satran D, Henry CR, Adkinson C, Nicholson CI, Bracha Y, Henry TD. Cardiovascular manifestations of moderate to severe carbon monoxide poisoning. Journal of the American College of Cardiology. 2005;45(9):1513-6.
3- Grieb G, Simons D, Piatkowski A, Altiok E, Eppstein RJ, Bernhagen J, et al. Carbon monoxide intoxication versus myocardial infarction: An easy diagnosis?. Burns: journal of the International Society for Burn Injuries. 2011;37(4):e29-31.
4- Hsu PC, Lin TH, Su HM, Lee HC, Huang CH, Lai WT, et al. Acute carbon monoxide poisoning resulting in ST elevation myocardial infarction: a rare case report. The Kaohsiung journal of medical sciences. 2010;26(5):271-5.
5- Dileo PA, Tucciarone M, Castro ER, Guerrero M. Late stent thrombosis secondary to carbon monoxide poisoning. Cardiovascular Revascularization Medicine. 2011;12(1):56-8.
6- Vidyasagaran AL, Siddiqi K, Kanaan M. Use of smokeless tobacco and risk of cardiovascular disease: A systematic review and meta-analysis. European journal of preventive cardiology. 2016;23(18):1970-81.
7- Ali WM, Al-Aqeedi RF, Gehani AA. Acute myocardial infarction in a young adult male associated with the use of smokeless tobacco (Sweka). Heart views: the official journal of the Gulf Heart Association. 2011;12(4):169.
8- Lippi G, Rastelli G, Meschi T, Borghi L, Cervellin G. Pathophysiology, clinics, diagnosis and treatment of heart involvement in carbon monoxide poisoning. Clinical biochemistry. 2012;45(16-17):1278-85.
9- Grieb G, Simons D, Piatkowski A, Altiok E, Eppstein RJ, Bernhagen J, et al. Carbon monoxide intoxication versus myocardial infarction: An easy diagnosis?. Burns: journal of the International Society for Burn Injuries. 2011;37(4):e29-31.
10- Tritapepe L, Macchiarelli G, Rocco M, Scopinaro F, Schillaci O, Martuscelli E, et al. Functional and ultrastructural evidence of myocardial stunning after acute carbon monoxide poisoning. Critical care medicine. 1998;26(4):797-801.
11- Symons R, Masci PG, Francone M, Claus P, Barison A, Carbone I, et al. Impact of active smoking on myocardial infarction severity in reperfused ST-segment elevation myocardial infarction patients: the smoker's paradox revisited. European heart journal. 2016;37(36):2756-64.
12- Mehrotra R, Yadav A, Sinha DN, Parascandola M, John RM, Ayo-Yusuf O, et al. Smokeless tobacco control in 180 countries across the globe: call to action for full implementation of WHO FCTC measures. The Lancet Oncology. 2019;20(4):e208-17.
13- Etemadi A, Khademi H, Kamangar F, Freedman ND, Abnet CC, Brennan P, et al. Hazards of cigarettes, smokeless tobacco and waterpipe in a Middle Eastern Population: a Cohort Study of 50 000 individuals from Iran. Tobacco control. 2017;26(6):674-82.
14- Ambrose JA, Barua RS. The pathophysiology of cigarette smoking and cardiovascular disease: an update. Journal of the American college of cardiology. 2004;43(10):1731-7.
15- Piano MR, Benowitz NL, FitzGerald GA, Corbridge S, Heath J, Hahn E, et al. American Heart Association Council on Cardiovascular Nursing. Impact of smokeless tobacco products on cardiovascular disease: implications for policy, prevention, and treatment: a policy statement from the American Heart Association. Circulation. 2010;122(15):1520-44.
16- Teo KK, Ounpuu S, Hawken S, Pandey MR, Valentin V, Hunt D, et al. Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study. The lancet. 2006;368(9536):647-58.
17- Ram RV, Trivedi AV. Smoking Smokeless Tobacco Consumption & Coronary Artery Disease-A Case Control Study. Natl J Community Med. 2012;3(2):264-8.
18- Janzon E, Hedblad B. Swedish snuff and incidence of cardiovascular disease. A population-based cohort study. BMC cardiovascular disorders. 2009;9(1):21.
19- Huhtasaari F, Asplund K, Lundberg V, Stegmayr B, Wester PO. Tobacco and myocardial infarction: is snuff less dangerous than cigarettes?. Bmj. 1992;305(6864):1252-6.
20- Henley SJ, Thun MJ, Connell C, Calle EE. Two large prospective studies of mortality among men who use snuff or chewing tobacco (United States). Cancer Causes & Control. 2005;16(4):347-58.
21- Hergens MP, Alfredsson L, Bolinder G, Lambe M, Pershagen G, Ye W. Long‐term use of Swedish moist snuff and the risk of myocardial infarction amongst men. Journal of internal medicine. 2007;262(3):351-9.